183 related articles for article (PubMed ID: 15773736)
1. Treatment of venous thromboembolism.
Eichinger S
Wien Med Wochenschr; 2005 Jan; 155(1-2):7-10. PubMed ID: 15773736
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Büller HR; Agnelli G; Hull RD; Hyers TM; Prins MH; Raskob GE
Chest; 2004 Sep; 126(3 Suppl):401S-428S. PubMed ID: 15383479
[TBL] [Abstract][Full Text] [Related]
3. [Initial treatment of venous thromboembolic events].
Mismetti P; Decousus H; Moulin N
Rev Prat; 2007 Apr; 57(7):751-7. PubMed ID: 17626320
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ
Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Kearon C; Akl EA; Comerota AJ; Prandoni P; Bounameaux H; Goldhaber SZ; Nelson ME; Wells PS; Gould MK; Dentali F; Crowther M; Kahn SR
Chest; 2012 Feb; 141(2 Suppl):e419S-e496S. PubMed ID: 22315268
[TBL] [Abstract][Full Text] [Related]
6. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
7. [Anticoagulation in patients with venous thromboembolism].
Rüfer A; Wuillemin WA
Ther Umsch; 2003 Jan; 60(1):43-7. PubMed ID: 12638478
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG).
Di Minno G; Tufano A; Cerbone AM
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):41-62. PubMed ID: 11383324
[TBL] [Abstract][Full Text] [Related]
9. Management of venous thromboembolism: a systematic review for a practice guideline.
Segal JB; Streiff MB; Hofmann LV; Thornton K; Bass EB
Ann Intern Med; 2007 Feb; 146(3):211-22. PubMed ID: 17261856
[TBL] [Abstract][Full Text] [Related]
10. Tinzaparin in the treatment of venous thromboembolism.
Pineo GF; Hull RD
Expert Opin Pharmacother; 2003 Dec; 4(12):2355-62. PubMed ID: 14640933
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
Prandoni P
Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
van Der Heijden JF ; Hutten BA; Büller HR; Prins MH
Cochrane Database Syst Rev; 2000; (4):CD002001. PubMed ID: 11034739
[TBL] [Abstract][Full Text] [Related]
14. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.
Hutten BA; Prins MH; Gent M; Ginsberg J; Tijssen JG; Büller HR
J Clin Oncol; 2000 Sep; 18(17):3078-83. PubMed ID: 10963635
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of deep vein thrombosis. When to use which substance?].
Bauersachs RM
Internist (Berl); 2004 Dec; 45(12):1345-55. PubMed ID: 15517122
[TBL] [Abstract][Full Text] [Related]
16. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
Hillis C; Crowther MA
Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ
Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291
[TBL] [Abstract][Full Text] [Related]
18. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
[TBL] [Abstract][Full Text] [Related]
19. [Therapy and secondary prevention of venous thromboembolism with vitamin K antagonists].
Bauersachs RM
Internist (Berl); 2003 Dec; 44(12):1491-9. PubMed ID: 14689191
[TBL] [Abstract][Full Text] [Related]
20. The use of antithrombotic drugs in older people.
Tufano A; Cerbone AM; Di Minno G
Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
